This month we go all buggy, thinking about how we can use EU-level regulatory frameworks to help us act in our clinical lives (https://adc.bmj.com/content/107/5/507.2). We also address the persuasive power of an accelerated BCG reaction in children… fort noted by Koch of Koch’s Postulates in rodents (https://adc.bmj.com/content/107/5/507.1), and ask a partially useful question that might save many hours and many many stabs - are CVC concentrations of tobramycin good enough to judge how to dose in children? (https://adc.bmj.com/content/107/5/512).

Please do tell us what you think of the podcast or the section, and if you’re revisiting the Journey to the West in TV form, on any of the socials.